[Resistance to rifampicin. In vitro and in vivo studies].
D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001419:Bacteria / Q000187:drug effects*; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D004926:Escherichia coli / Q000187:drug effects; D006801:Humans; D009154:Mutation; D011511:Proteus / Q000187:drug effects; D011549:Pseudomonas / Q000187:drug effects; D012293:Rifampin / Q000008:administration & dosage / Q000494:pharmacology*; D012706:Serratia marcescens / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D014552:Urinary Tract Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D012293:Rifampin
Résistance à la rifampicine. Observations in vitro et in vivo.